Press releases

Pharmacy

Researchers monitor mRNA to help time its great escape to perfection

9 June, 2021 - Chalmers tekniska högskola

The ease by which mRNA-based drugs are taken up by cells in tissues is crucial to their therapeutic effectiveness. Now, a new detection method developed by researchers at Chalmers University of Technology, Sweden, and AstraZeneca could lead to faster and better development of the small droplets known as lipid nanoparticles, which are the main method […]

Transport system in the human brain studied in new dissertation

12 March, 2021 - Linnéuniversitetet

Proteins are often called the building stones of our bodies – rightly so. Almost everything that goes on in our bodies involves proteins in one way or another. In a new dissertation in chemistry, Dick Sjöström zooms in on a specific transport protein which we could use to develop medicines and treatment for, among other […]

Antibiotic resistance may spread even more easily than expected

21 January, 2021 - Chalmers tekniska högskola

Pathogenic bacteria in humans are developing resistance to antibiotics much faster than expected. Now, computational research at Chalmers University of Technology shows that one reason could be significant genetic transfer between bacteria in our ecosystems and to humans. This work has also led to new tools for resistance researchers. According to the World Health Organisation, […]

Sweden’s new innovation centre for information driven care

10 September, 2020 - Högskolan i Halmstad

Leap for Life is a new innovation centre for information driven care. It is a joint initiative in the county of Halland for a collaborative effort in future healthcare between Halmstad University, Region Halland, all municipalities in Halland and the region’s business sector.

New knowledge of the muscular system important for future treatment of diseases

16 October, 2019 - Linnéuniversitetet

When a muscle is activated, it is the proteins myosin and actin that go to work. Myosin molecules take hold of actin molecules and pull, like rope pulling, in a process that gets energy from the use of the cellular fuel ATP. In his dissertation, Mohammad Ashikur Rahman has conducted extensive studies of the mechanical […]

New biomarker may uncover uncontrolled asthma  

20 August, 2019 - Karolinska Institutet

Cytokines are a type of proteins that are important to the signaling between cells in the body’s immune system, for example in the case of an infection or injury. A new study which is being published in the Journal of Allergy and Clinical Immunology is now indicating that the cytokine interleukin(IL)-26 could be used as a biological marker (biomarker) for uncontrolled asthma in both adults and children – and could perhaps also be a future goal for new drugs against asthma. These results are presented by researchers at Karolinska Institutet and Lund University.

Statins can prevent liver cancer

20 August, 2019 - Karolinska Institutet

Fat-soluble statins can prevent liver cancer and reduce mortality in patients with chronic viral hepatitis. These are findings from a study conducted by researchers at Karolinska Institutet in Sweden, among others. The study is published in Annals of Internal Medicine.

Novel findings explain indirect regulation of glucose homeostasis

16 August, 2019 - Karolinska Institutet

The hormone secreting part of the pancreas, the islets of Langerhans, has a unique cyto-architecture that allows functional interrelationships between the different cell types. Somatostatin is secreted by the delta cell and is an effective inhibitor of the insulin secreting beta cell and the glucagon secreting alpha cell. According to a novel study from Sweden’s Karolinska Instiutet, published in the journal Nature Communications, the delta cell can thereby indirectly affect glucose homeostasis in health and disease.

Hormonal therapy has a long-term effect in breast cancer

8 August, 2019 - Karolinska Institutet

Researchers at Karolinska Institutet in Sweden have investigated the long-term effect of hormonal therapy in women with the most common types of hormone-sensitive breast cancer. The results, presented in the journal JAMA Oncology, show that the treatment has a protective effect against distant metastatic cancer for both so-called Luminal A and Luminal B breast cancer subtypes, and a long-term effect for women diagnosed with Luminal A cancer.

New project to improve drugs safety in East Africa

4 September, 2018 - Karolinska Institutet

In recent years access to drugs and vaccines has been increasing in many African countries, but the systems for monitoring treatment effects and reporting side-effects require further development. Karolinska Institutet in Sweden will now lead an international collaboration project on pharmacovigilance – drugs safety – in four countries in East Africa.